HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 11, November 2018 – The Asian Cancer - War on liver cancer       » 2018 Nobel Prize in Physiology or Medicine winners       » Women more prone to selected chemotherapy side effects       » Tibetan fungus could help fight liver cancer       » Standards for TCM decoction to be applied globally       » RMB200 million donation to build Tsinghua University Biomedical Sciences Building      
EYE ON CHINA
Proposed law change to increase penalties for drug violations
Violations such as making or selling fake drugs could see companies lose their business licenses

The penalties for companies that produce or sell fake or substandard pharmaceuticals in China are to be increased, according to a draft amendment to the country's Drug Management Law.

Manufacturers that operate without the required permit will face fines up to 30 times the value of their products. Under the current law, the maximum fine is five times the value.

The proposed amendment, now under review by the National People's Congress Standing Committee, the top legislature, states that violations such as making or selling fake drugs could see companies lose their business license.

Business executives and drug supervision officials will also face heavier punishment in cases involving pharmaceuticals, while supervision of certain drugs, such as vaccines, will be intensified to ensure safety and quality.

Jiao Hong, head of the National Medical Products Administration, said the draft aims to improve supervision of drugs following the vaccine scandal at Changchun Changsheng Biotech, a major vaccine producer in Jilin province.

The administration fined the company 9.1 billion yuan ($1.3 billion) for fabricating production records and using expired materials to manufacture a human rabies vaccine.

Source: China Daily

Click here for the complete issue.

NEWS CRUNCH  
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
news Vitafoods Asia expands by 40 per cent in 2018
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management - Technologies for biotech and pharmaceutical industries
August:
Regenerative technology - Meat of the future
September:
Doctor Robot - The digital healthcare revolution
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy